Abstract
The molecular target therapy of non-small cell lung cancer (NSCLC) has become a hot research direction in the field of medicine. Following the discovery of well-known tumor-driven genes such as epidermal growth factor receptor (EGFR), Kirsten rat sarcoma viral oncogene (KRAS) and anaplastic lymphoma kinase (ALK) genes, more and more scholars have shifted focus to ROS1 fusion gene. The protein encoded by ROS1 is a member of the receptor tyrosine kinase super family, and it plays an important role in cell growth and cell survival. ROS1 fusion gene plays a vital role in the occurrence, development and clinical treatment of NSCLC. Key words: Carcinoma, non-small-cell lung; ROS1 fusion gene; Crizotinib; Molecular targeted the-rapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
